Literature DB >> 11998545

Should cases with a 'known' cause of their disease be excluded from study? (commentary).

K J Rothman1, W Ray.   

Abstract

Assigning a cause to an individual event is a natural impulse. This impulse sometimes finds its way into epidemiologic research, if researchers assign a specific cause to some cases of a disease under study. In epidemiologic studies of drug effects, assigning a cause to specific cases is often used as a reason to exclude these cases from cohort or case-control studies, because the disease in these cases is thought to be the result of a 'known cause'. These exclusions are invalid. It is always valid, however, to exclude all subjects with 'known' causes from a study, cases from the numerator and the people or person-time at risk from the denominator (or from the control series in a case-control study). If the exclusions from the denominator would be negligibly small or the relative number of excluded cases with 'known' causes is small, then the exclusion of just the cases with 'known' causes will introduce little bias.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11998545     DOI: 10.1002/pds.683

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  3 in total

1.  Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database.

Authors:  Nancy D Lin; Heather Norman; Arie Regev; David G Perahia; Hu Li; Curtis Liming Chang; David D Dore
Journal:  BMC Gastroenterol       Date:  2015-10-14       Impact factor: 3.067

2.  Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.

Authors:  Alejandro Arana; Catherine B Johannes; Lisa J McQuay; Cristina Varas-Lorenzo; Daniel Fife; Kenneth J Rothman
Journal:  Drug Saf       Date:  2015-12       Impact factor: 5.606

3.  Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions.

Authors:  Mirjam Hempenius; Rolf H H Groenwold; Anthonius de Boer; Olaf H Klungel; Helga Gardarsdottir
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-08-02       Impact factor: 2.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.